Clerisy has an experienced Board and Management team, national and international distribution relationships, proprietary medical delivery-device technology and a multi-faceted growth strategy focused on opportunities in the global consumer health market.
Welcome to Clerisy Corporation
Why Invest in Clerisy?
Clerisy brings several key investment differentiators and competitive advantages to bear.
World Renowned Medical Expertise
Proprietary Medical Delivery Devices
Exit Strategy & Path To Liquidity
Mass Market Opportunity
RxMM and Clerisy announced that Clerisy has engaged Tycon Partners a Reg A+ Specialist operation based in Manhattan, New York to raise up to $25million in new capital to fund Clerisy’s product launch planned for Q2-17. » Download Tycon Partners Announcement (PDF)